Covid-19 has shaken world markets and a question on the minds of many investors right now is how economic uncertainty will continue to affect small-cap shares like Hyphens Pharma International (SGX:1J5). Shares in the company are curre...
1J5 — Hyphens Pharma International Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeSmall CapSuper Stock
- SG$94.18m
- SG$82.88m
- SG$125.88m
- 93
- 50
- 97
- 96
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 11.28 | ||
| PEG Ratio (f) | 1.09 | ||
| EPS Growth (f) | 11.58% | ||
| Dividend Yield (f) | 2.62% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.72 | ||
| Price to Tang. Book | 2.73 | ||
| Price to Free Cashflow | 18.1 | ||
| Price to Sales | 0.75 | ||
| EV to EBITDA | 7.39 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 16.17% | ||
| Return on Equity | 13.45% | ||
| Operating Margin | 7.17% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SG$m | 112.65 | 120.93 | 119.44 | 123.7 | 125.88 | 145 | 151.4 | 4.51% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +10.88 | -18.21 | +4.87 | -11.4 | +15.87 | +16.38 | +7.69 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for 1J5
Shares in Hyphens Pharma International (SGX:1J5) are currently trading at 0.345 but a key question for investors is how the economic uncertainty caused by Covid-19 will affect the price. The answer comes down to judging whether it is w...
An important question for small-cap investors right now is whether the current market uncertainty caused by Covid-19 will affect the share prices of companies like Hyphens Pharma International. Hyphens Pharma International shares are c...
Economic shockwaves caused by Covid-19 have plunged stock markets into turmoil, but some shares are better able to absorb this volatility than others - and Hyphens Pharma International (SGX:1J5) could be one of them. To understand why...
Shares in Hyphens Pharma International (SGX:1J5) are currently trading at 0.3 but the question for investors is how much the market chaos of 2020 will impact its share price. The answer comes down to judging whether Hyphens Pharma Inte...
Profile Summary
Hyphens Pharma International Limited is a Singapore-based investment holding company. The Company’s principal activity is the provision of management services. The Company operates through three segments: Specialty Pharma Principals, Proprietary Brands, and Medical Hypermart and Digital. Specialty pharma principals segment is in the business of marketing and selling a range of pharmaceutical products with exclusivity in the relevant the Association of Southeast Asian Nations countries. Proprietary brands segment is in the business of developing, marketing and selling its own range of dermatological products and health supplement products. Medical hypermart and digital segment is a wholesaler of pharmaceuticals and medical supplies in Singapore, which the Company positions itself as a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies.
Directors
- Last Annual
- December 31st, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- December 12th, 2017
- Public Since
- May 18th, 2018
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Singapore Exchange Securities Trading Ltd
- Shares in Issue
- 308,776,200
- Address
- 16 Tai Seng Street, Level 4, 534138
- Web
- https://www.hyphensgroup.com/
- Phone
- +65 62965751
- Auditors
- RSM Chio Lim
Upcoming Events for 1J5
Similar to 1J5
Haw Par
Singapore Exchange Securities Trading Ltd
IX Biopharma
Singapore Exchange Securities Trading Ltd
Pharmesis International
Singapore Exchange Securities Trading Ltd
Suntar Eco-City
Singapore Exchange Securities Trading Ltd
FAQ
What is the Hyphens Pharma International share price?
As of Today at 07:11 UTC, shares in Hyphens Pharma International are trading at SG$0.31. This share price information is delayed by 15 minutes.
How has the Hyphens Pharma International share price performed this year?
Shares in Hyphens Pharma International last closed at SG$0.31 and the price had moved by -7.58% over the past 365 days. In terms of relative price strength the Hyphens Pharma International share price has outperformed the FTSE Developed Asia Pacific Index by +22.12% over the past year.
What are the analyst and broker recommendations for Hyphens Pharma International?
The overall consensus recommendation for Hyphens Pharma International is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Hyphens Pharma International dividend yield?
The Hyphens Pharma International dividend yield is 2.2% based on the trailing twelve month period.
Does Hyphens Pharma International pay a dividend?
Last year, Hyphens Pharma International paid a total dividend of SG$0.01, and it currently has a trailing dividend yield of 2.2%. We do not have any data on when Hyphens Pharma International is to next pay dividends.
When does Hyphens Pharma International next pay dividends?
We do not have data on when Hyphens Pharma International is to next pay dividends. The historic dividend yield on Hyphens Pharma International shares is currently 2.2%.
How do I buy Hyphens Pharma International shares?
To buy shares in Hyphens Pharma International you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hyphens Pharma International?
As of the previous close price of SG$0.31, shares in Hyphens Pharma International had a market capitalisation of SG$94.18m.
Where are Hyphens Pharma International shares listed?
Here are the trading details for Hyphens Pharma International:
- Country of listing: Singapore
- Exchange: SES
- Ticker Symbol: 1J5
What kind of share is Hyphens Pharma International?
Based on an overall assessment of its quality, value and momentum Hyphens Pharma International is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hyphens Pharma International share price forecast for 2022?
The analyst consensus target price for shares in Hyphens Pharma International is SG$0.38. That is 23.93% above the last closing price of SG$0.31.
Analysts covering Hyphens Pharma International currently have a consensus Earnings Per Share (EPS) forecast of SG$0.03 for the next financial year.
What is the trend in the Hyphens Pharma International share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hyphens Pharma International. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +20.01%.
As of the last closing price of SG$0.31, shares in Hyphens Pharma International were trading +2.16% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hyphens Pharma International PE Ratio?
The Hyphens Pharma International PE ratio based on its reported earnings over the past 12 months is 11.28. The shares last closed at SG$0.31.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hyphens Pharma International?
We do not have data on Hyphens Pharma International's directors